Oral Anticancer Therapy Monitoring Note

Date/Time: [Date and time of encounter]

Encounter Type: [in-person / video / telephone]

Provider: [Clinician name and role]

Participants: [patient alone / caregiver present / interpreter used]

Current Oral Anticancer Therapy

Drug/Regimen: [Drug name(s) and regimen name if applicable]

Dose/Schedule: [Dose, frequency, cycle structure, on/off days]

Cycle/Day or Duration: [Cycle and day OR total duration on therapy]

Start Date: [Therapy start date]

Current Status: [continuing as prescribed / held / reduced / restarted]

(If regimen details cannot be confirmed, document "Regimen details not confirmed today" and add reconciliation steps under Plan.)

Subjective

[Interval history since last contact including hospitalizations, infections, new diagnoses, functional changes, and response updates if known]

Adherence: [Quantified adherence over defined interval, e.g., "X missed doses in past Y days"] (State information source: patient report, caregiver, pill count, or pharmacy fill history. Note timing deviations, incorrect on/off days, missed-dose behavior, and screen for overadherence. Do not use unqualified terms like "compliant." If adherence cannot be assessed, state reason and plan to obtain data.)

Barriers: [Barriers identified: side effects, cost/access, health literacy, cognitive limitations, swallowing issues, social determinants] (If none identified, document "no barriers identified today.")

Toxicity/Symptoms: [Pertinent symptoms by relevant domains—GI, dermatologic, hematologic signs, cardiopulmonary, neurologic, drug-specific concerns] (For each significant finding, include severity grade with basis for grading. Screen for red flags: fever ≥38°C, significant bleeding, dyspnea at rest. If a domain was not assessed, state "not assessed" rather than implying negative. Summarize top toxicities and impact on therapy decisions.)

Objective

Labs: [Key results with collection date, abnormal values highlighted, trends noted] (Provide interpretation: "meets treatment parameters" or "does not meet parameters" with specific concern. If required labs pending or not obtained, document this and the risk decision.)

Vitals/Weight/PS: [Vital signs, weight change, performance status as relevant] (Omit if not obtained.)

Medication Reconciliation: [Active medications including OTC/herbals, new medications since last visit] (Document interaction review: "no clinically significant interactions" or specify interaction and action taken. If incomplete, state what remains unknown.)

Assessment

(Organize by problem in decreasing clinical severity. Each problem should include a brief assessment statement.)

[Cancer diagnosis / OAM regimen status: on therapy, held, reduced, response status]

[Treatment toxicities: named toxicities with grade and impact on continuation]

[Lab abnormalities: relevance to dosing parameters]

[Adherence barriers: impact on safe/effective therapy]

[Relevant comorbidities if affecting therapy decisions]

(Decisions to continue, hold, reduce, or discontinue must be explicitly stated as clinician decisions.)

Plan

Dose Decision: [continue / hold / reduce / discontinue / switch] (If modifying: prior dose → new dose, effective date, reason with toxicity grade or lab threshold, and restart criteria if held.)

Supportive Care: [Symptom management measures with escalation thresholds]

Adherence Interventions: [Education reinforcement, missed-dose instructions reviewed, referrals to navigation or financial counseling if barriers exist]

Refill Authorization: [Last fill date and supply remaining] | [Eligibility: adherence assessed, toxicity acceptable, labs reviewed] | [Action: prescription sent / pharmacy contacted / REMS steps / dose change communicated] (If deferred, state reason and trigger for release. Do not authorize based solely on patient-reported well-being.)

Follow-Up: [Next labs and timing] | [Next visit date/interval/modality] | [Imaging or response assessment plan if applicable]

Patient Education: [Administration instructions, missed-dose guidance, safe handling/storage/disposal, red-flag symptoms reviewed] (Document teach-back confirmation.)

Care Coordination: [External contacts: specialty pharmacy, REMS, navigation, financial counselor with date and outcome] (Omit if none.)

Orders: [Labs, imaging, supportive meds, referrals placed]